SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Clarity Pharmaceuticals Rises as Prostate Cancer Trial Meets Enrollment Target

Clarity Pharmaceuticals shares climbed after its prostate cancer trial met its enrollment target.

Related stories